1、 Price trend:

According to the data of business club’s block list, the domestic PA6 market fell on May 25, and the spot price dropped significantly. As of May 25, the mainstream offer price of sample enterprises for CNMC 2.75-2.85 was about 15166.67 yuan / ton, with a one-day drop of 2.15%, up 31.12% over the same period of last year.

2、 The influencing factors were analyzed

In terms of upstream caprolactam, the domestic market is relatively strong in the near future. The spot price fell today after finishing sideways on the 24th. The price of caprolactam liquid of Luxi Chemical Co., Ltd. was reduced to 13200 yuan / T, with a capacity of 300000 tons and normal production of the plant. The price of Baling Hengyi caprolactam liquid was reduced to 14400 yuan / ton, and the 450000 ton / year unit was started normally and delivered by acceptance. The price of caprolactam liquid in Baling Petrochemical Company is 14400 yuan / T. The 300000 t / a unit is normally started and delivered by acceptance. In terms of raw material pure benzene, crude oil and external market fell in a wide range last week, while external news was bad for pure benzene, and the price fell continuously. The cost side support from raw material pure benzene gradually weakened, and caprolactam followed the upstream.

Raw material caprolactam market from up to down, PA6 cost side support reversed. Last month, PA6 spot market has continued to fall for more than a month, after the festival market rebound with caprolactam. Today, the upstream support is loose, and the main positive factors will be weakened in the short term. In addition, the recent downstream factory purchase operation is cautious, and the follow-up is slow. Trading on the floor was weak, and the actual trading momentum was poor. The profit situation of polymerization plant continued to be in the pattern of loss, the decline of engineering materials and chips was similar, and the inventory of the enterprise was on the rise.

，

3、 Future forecast:

Business analysts believe that: on May 25, the upstream caprolactam market of PA6 stagnated and turned to decline, and the recent cost side support guidance market of PA6 suffered a drastic decline, with a large one-day decline. There is no large-scale demand in downstream factories, and the end-user mentality is not strong, so the operation is mainly cautious. Overall, the current PA6 market is short, and the spot price is expected to continue to fall.